Related Experiment Video
Updated: Aug 29, 2025

09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
753
Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor-modified T-cell
Michael A Gonzalez1,2, Atif M Bhatti1, Kristin Fitzpatrick1
1Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA.
Blood Advances
|September 12, 2022
Abstract
No abstract available in PubMed .
More Related Videos
08:09Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level
Published on: March 14, 2025
1.1K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.4K
Related Concept Videos
Tumor Immunotherapy
643
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
Vaccinations
45.2K
Overview
45.2K
Cell-mediated Immune Responses
70.0K
Overview
70.0K
Humoral Immune Responses
73.9K
Overview
73.9K